Literature DB >> 29188430

Undiagnosed mitroflow bioprosthesis deformation causing early structural valve deterioration.

Marco Gennari1, Gianluca Polvani2,3, Mara Rubino2, Francesco Arlati2, Andrea Annoni2, Marco Agrifoglio2,3.   

Abstract

Bioprosthesis are commonly used in the elderly population. Structural valve deterioration affects the long-term durability. We report an early deterioration of a Mitroflow valve caused by ring deformation and prosthetic leaflet rupture. The 69-years-old patient underwent successful redo surgery with excision of the bioprosthesis and placement of a mechanical valve.

Entities:  

Keywords:  Bioprosthesis; Cardiac surgery; Redo surgery; Structural valve deterioration

Mesh：

Year:  2017        PMID： 29188430     DOI： 10.1007/s11748-017-0868-8

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  5 in total

1.  Is distortion of the bioprosthesis ring a risk factor for early calcification?

Authors:  Jose Manuel Martinez Cereijo; Jose Rubio Alvarez; Juan Sierra Quiroga; Anxo Martinez de Alegria; Jose Manuel Suarez Peñaranda
Journal:  J Cardiothorac Surg       Date:  2010-10-07       Impact factor: 1.637

2.  Saphenous vein cannulation in re-redo cardiac surgery.

Authors:  Marco Agrifoglio; Marco Gennari; Samer Kassem; Gianluca Polvani
Journal:  J Card Surg       Date:  2012-10-15       Impact factor: 1.620

3.  Pathologic evaluation of 28 Mitroflow pericardial valves: a 12-year experience.

Authors:  Adriana Luk; Robert J Cusimano; Jagdish Butany
Journal:  Ann Thorac Surg       Date:  2014-11-06       Impact factor: 4.330

4.  Early prosthetic valve degeneration with Mitroflow aortic valves: determination of incidence and risk factors†.

Authors:  Vijay Joshi; Kaye Prosser; David Richens
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-03-25

5.  Mitroflow pericardial bioprosthesis: structured failure at 4.5 years.

Authors:  Jagdish Butany; Tianshu Feng; Rahul Suri; Kelsey Law; George Christakis
Journal:  Cardiovasc Pathol       Date:  2012 Nov-Dec       Impact factor: 2.185
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.